日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant

在一项针对巨细胞病毒血清阳性异基因造血干细胞移植受者的来特莫韦预防性治疗的3期随机、安慰剂对照试验中,对巨细胞病毒特异性细胞介导免疫的分析

Papanicolaou, Genovefa A; Dadwal, Sanjeet S; Ariza-Heredia, Ella J; Chiusolo, Patrizia; Morris, Michele I; Tholouli, Eleni; Haber, Barbara; Broyde, Natalya; Gilbert, Christopher L; Badshah, Cyrus

Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity for Prediction of Postprophylaxis CMV Disease in a Phase 3 Trial of Letermovir Versus Valganciclovir Prophylaxis in Donor CMV-Seropositive/Recipient CMV-Seronegative Kidney Transplant Recipients

在供体 CMV 血清阳性/受体 CMV 血清阴性的肾移植受者中,来特莫韦与缬更昔洛韦预防治疗的 3 期试验中,巨细胞病毒 (CMV) 特异性细胞介导免疫用于预测预防后 CMV 疾病

Limaye, Ajit P; Crespo, Marta; Kamar, Nassim; Humar, Atul; Carroll, Robert P; Pereira, Marcus R; Broyde, Natalya; Wang, Weiwen; Haber, Barbara

Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b study

在接受造血干细胞移植的儿童(出生至<18岁)患者中,使用来特莫韦进行巨细胞病毒预防:一项2b期研究的药代动力学、疗效和安全性结果

Groll, Andreas H; Danziger-Isakov, Lara; Gefen, Aharon; Fraser, Christopher J; Schulte, Johannes H; Bielorai, Bella; Karras, Nicole A; Bueno, David; Shaw, Peter J; Broyde, Natalya; Haber, Barbara; Gilbert, Christopher L; Patel, Mayankbhai; McCrea, Jacqueline B; Badshah, Cyrus

The Mitigating Effect of Combined Glucocorticoids with Immune Checkpoint Inhibitors on Lymphocyte Activation Gene-3 and Programmed Death-1 Expression

糖皮质激素与免疫检查点抑制剂联合应用对淋巴细胞活化基因-3和程序性死亡-1表达的缓解作用

Smadar Gertel ,Ari Polachek ,Victoria Furer ,Tali Ofir Dovrat ,Chen Avaky ,Adi Broyde ,Hila Nochimovitz ,Ori Elkayam

Peptide Sequence and Cross-Link Structure Influence Translesion Synthesis Polymerase Bypass of 5-Formylcytosine-Mediated DNA-Peptide Cross-Links

肽序列和交联结构影响跨损伤合成聚合酶绕过5-甲酰胞嘧啶介导的DNA-肽交联

Zhang, Qi; Fu, Iwen; Broyde, Suse; Tretyakova, Natalia Y

A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections

一项评估磷酸替地唑胺治疗12岁以下急性细菌性皮肤及皮肤结构感染患者的安全性和有效性的3期研究

Mngqibisa, Rosie; Fofanov, Oleksandr; Grazioso, Carlos F; Melgar Toledo, Mario; Boddicker, Melissa; Broyde, Natalya; Koseoglu, Sandra; Romero, Lizbeth; Stevens, Mara; Sears, Pamela

Variable Inhibition of DNA Unwinding Rates Catalyzed by the SARS-CoV-2 Helicase Nsp13 by Structurally Distinct Single DNA Lesions

结构不同的单个DNA损伤对SARS-CoV-2解旋酶Nsp13催化的DNA解旋速率的抑制作用存在差异

Sales, Ana H; Fu, Iwen; Durandin, Alexander; Ciervo, Sam; Lupoli, Tania J; Shafirovich, Vladimir; Broyde, Suse; Geacintov, Nicholas E

UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma

UHRF1是肺腺癌中KRAS驱动的肿瘤发生的介质

Kaja Kostyrko ,Marta Román ,Alex G Lee ,David R Simpson ,Phuong T Dinh ,Stanley G Leung ,Kieren D Marini ,Marcus R Kelly ,Joshua Broyde ,Andrea Califano ,Peter K Jackson ,E Alejandro Sweet-Cordero

Differing structures and dynamics of two photolesions portray verification differences by the human XPD helicase

两种光损伤的不同结构和动力学表明,人类XPD解旋酶的验证存在差异。

Fu, Iwen; Geacintov, Nicholas E; Broyde, Suse

Mechanism of lesion verification by the human XPD helicase in nucleotide excision repair

人XPD解旋酶在核苷酸切除修复中验证损伤的机制

Fu, Iwen; Mu, Hong; Geacintov, Nicholas E; Broyde, Suse